Fifteen prints in one issue, most of them enterprise software in the middle of an AI transition — so the reusable methods here are about separating adoption from monetization, stripping acquisitions and tax items out of a growth rate, reading the recurring-revenue metrics in the order they actually turn, and deciding whether a beat-and-raise that still fell was about the business or about the price. Not whether to buy, but which disclosure to demand before you believe the story.
1. Separate AI adoption from AI monetization — count the customers on the meter, not the customers using the feature
The repeatable method
- For every AI claim in a print, sort the disclosed numbers into two buckets: adoption (users, customers touching a feature, MAUs, deals closed, penetration) and monetization (ARR, ACV, revenue, customers on a paid plan or usage meter).
- If a company discloses only adoption metrics, assume the revenue is immaterial until it says otherwise — a company with meaningful AI revenue reports it, because it is the better number.
- Where both are given, compute the conversion ratio directly: paying customers ÷ using customers. That single fraction is the entire state of the monetization effort.
- Read management's stated reason for a low ratio. "Deliberately prioritizing adoption" is a strategy with a timetable — demand the timetable. Note whether the giveaway is reversible: usage customers have to accept a bill later, and habituation to free is a real cost.
- Then check what the AI is defending against. A per-seat vendor deploying agents that reduce headcount is cannibalizing its own billing unit, so the consumption meter is not upside — it is the replacement for revenue it is about to lose.
- Finally, prefer the disclosure that is cohort-scoped (penetration within customers above a spending threshold) to a company-wide total, which mixes free trials into the same figure as production deployments.
Here: the whole issue is a spectrum on this one test. WDAY gives both halves and the ratio is brutal — 5,500+ customers using at least one agent against "a little over 200" on Flex Credits (under 4%), with AI at >$100M of new ACV, 25%+ of all new ACV and ~$600M of AI-SKU ARR, deliberately un-metered as a "delayed gratification" model whose explicit purpose is to answer seat compression. OKTA states it outright: dozens of agent deals, several >$1M, but "AI-specific revenue is still immaterial and is unlikely to become meaningful in FY27." VEEV: Falcon at five early adopters — "still early adoption rather than meaningful revenue contribution." HQY: Marketplace at 14,000 members, "revenue remains immaterial." The best-constructed disclosure in the issue is ESTC's, because it is cohort-scoped — AI penetration of the $100K+ ACV cohort at 37%, from ~21% a year ago, on a cohort that itself grew past 1,800.
Watch for
- Workday's Flex Credits customer count each quarter — that number, not agent adoption, is the thesis; the first quarter a company stops disclosing the using-customer count (usually because the ratio got embarrassing); and any per-seat vendor whose seat count flattens before its consumption revenue starts.
2. Prefer the AI beneficiary whose revenue needs other people to deploy AI — and price the second-order effect, not the product
The repeatable method
- When a company launches an AI product, ask which line of its P&L actually benefits: the new product's own revenue, or the existing product that AI deployment forces customers to expand.
- Test for the second-order effect with three questions: does deploying agents create a new problem the incumbent already solves? Does it raise the deal size of the existing platform? Does it pull forward a modernization project that was previously deferred?
- Look for the corroborating metrics on the old business, not the new one: attach rate of newer modules to bookings, average deal size uplift, growth in the largest-customer cohort, and the contracted-revenue metric.
- Treat management candour about immaterial AI revenue as a positive signal, not a negative one — it means the growth being reported is coming from somewhere verifiable.
- Size the opportunity off the installed base being modernized, which is knowable, rather than off the new category's TAM, which is not.
Here: OKTA is the clean case — the agent product is immaterial, but "AI-agent security concerns are prompting customers to modernize their broader identity infrastructure," and the corroboration is all on the old platform: new products 30% of bookings from 25%, those deals carrying ~40% higher ACV, $1M+ customers +20% to over 600, cRPO accelerating to 14% from 12%, and the strongest non-Q4 bookings quarter ever. RBRK runs the same shape in cyber-resilience (Agent Cloud adding Claude Code support, five consulting firms joining Project Hourglass) while the paid metric that moved was plain subscription ARR. MRVL is the hardware version: it does not need to win the AI-model race, it needs hyperscalers to keep designing their own chips.
Watch for
- The new-product share of bookings stalling (the modernization wave has passed); deal-size uplift fading; and the moment a platform vendor starts guiding on a standalone AI revenue line, which converts a durable second-order story into a competitive first-order one.
3. Strip the acquisition out of the growth rate — then insist on the organic number the company was criticized for last quarter
The repeatable method
- When a headline growth rate jumps, first ask what was bought. Find the acquisition's revenue contribution and restate growth without it.
- Identify which specific organic line was the bear case in the previous quarter, and check whether the company disclosed that exact line again. A company that quietly stops breaking out the number it was criticized for is answering the question.
- For an acquisition, separate three distinct claims: revenue contribution (arithmetic), margin impact (does it dilute, and is the offset specified?), and cross-sell (the only one that creates value, and the last to appear).
- Check whether integration has produced joint products yet, not just combined revenue — a shipped combined product is the first real evidence the thesis is more than a bolt-on.
- Note the dilution defence precisely: "operating leverage and sales efficiencies fully offset the dilution" is a testable claim, so put it beside the unchanged margin guidance and check it next quarter.
Here: SNPS's +42% revenue is mostly Ansys — the number that matters is core EDA +8.5% with double-digit organic guided for Q4, plus Design IP back to +11% after −6% in Q2, precisely the two lines Q2 was criticized on. Integration is producing products, not just revenue: first Multiphysics Fusion launches and 30+ agentic-AI customer engagements. ADSK is the margin version — $3.6B MaintainX adds only ~$60M of FY27 revenue, and Autodesk raised revenue guidance while leaving the non-GAAP margin outlook intact, claiming efficiencies fully offset dilution; the cross-sell evidence is a single named win (a global retailer taking Forma + Tandem), and the author's open question is "meaningful cross-sell rather than simply a larger TAM story." RBRK is the control case: Strata contributed no ARR and is excluded from FY27 guidance, so its acceleration needs no adjustment at all.
Watch for
- The quarter the acquisition annualizes into the base and headline growth collapses to organic; margin guidance quietly trimmed a quarter or two after the "fully offset" claim; and cross-sell still being evidenced by one anecdote three quarters later.
4. Strip the tax item and the below-the-line gain before you read EPS at all
The repeatable method
- Whenever EPS is startlingly large relative to revenue, walk down to the tax line and the other-income line before comparing to consensus.
- Common one-offs to isolate: a valuation-allowance release or other non-recurring tax benefit, investment or fair-value marks, gains on consolidation, legal settlements, tariff or duty refunds.
- Re-underwrite on operating income and free cash flow, which these items do not touch, and treat the headline EPS as uninformative rather than good.
- Apply it symmetrically — a non-operating loss depressing EPS is equally meaningless, and is far more likely to be mispriced because the market reacts to the miss.
- Where the item is a tax benefit, check whether it changes the go-forward tax rate; if not, next year's EPS comparison will invert for purely mechanical reasons.
Here: twice in one issue, and the newsletter flags both. AFRM's GAAP EPS of $4.77 "was distorted by a $1.45B tax benefit, so it isn't particularly meaningful" — the readable numbers are GMV +36% to $14.1B and adjusted operating margin 27% → 30%. NTNX's Q4 was "polluted by a massive non-recurring $1.2B tax benefit" — read ARR +16% to $2.5B and a 37% free-cash-flow margin instead. This is the same audit App Economy has run on investment marks in both directions (Microsoft's Anthropic gain, NetEase's EPADS miss caused by investment losses rather than operations).
Watch for
- The following year's EPS comparison inverting on the missing benefit; a company quoting the boosted EPS in its own headline; and repeat "non-recurring" items, which stop being non-recurring by the third appearance.
5. When a company cuts its own price, separate the deliberate reset from the eroded moat — and audit any metric redefinition arriving with it
The repeatable method
- Find management's stated diagnosis of churn. A company that names price as its number one churn reason has just told you its pricing power is being tested, whatever the strategy it announces next.
- Separate the two possible readings and write down what would distinguish them: a deliberate reset should come with a specified reacceleration date, a target customer count, and a monetization path for the cheaply-acquired users; structural erosion comes with a lowered guide and no such specifics.
- Quantify the sacrifice explicitly — the growth rate of the reset product versus the group — so the cost of the strategy is on the page rather than buried in a range.
- Check whether the same playbook is being extended to other products. Repetition is evidence of a considered strategy; it is also evidence the same pressure exists in more than one market.
- Independently, run the redefinition audit: if a headline metric's definition changes in the same print, refuse to compare it to prior consensus until a bridge is published. Note the direction — a redefinition that makes the company look worse (adding a real cost back in) is far more credible than one that flatters.
Here: INTU beat on Q4 (+14% to $4.35B, EPS $4.03) and fell sharply on FY27 growth guided to 9%–10% from 14%. The diagnosis is stated: "price has become the #1 reason DIY customers leave, particularly among filers earning around $50,000," so Intuit will "accept lower revenue per customer" — TurboTax guided to just 2%–3% — and is extending the same move to QuickBooks Free (20,000+ customers) on a monetize-later theory (payments, payroll, lending). The redefinition sits in the same paragraph: the FY27 EPS shortfall "is less concerning than it looks because Intuit will begin including stock-based compensation in its non-GAAP results, making the new EPS guidance incomparable with prior estimates." Bottom Line: "a deliberate reset before reacceleration or evidence that competition is structurally weakening Intuit's pricing power." Compare the precedent in this source's archive — Salesforce widening its Agentforce ARR definition, Klarna's new Fair Financing treatment arriving with a raised margin outlook.
Watch for
- The FY27 TurboTax growth rate against the 2%–3% guide (undershooting turns "deliberate" into "structural"); free-tier conversion rates actually disclosed rather than the free user count; Mailchimp's flat-to-down trajectory; and whether the SBC-inclusive EPS bridge is ever published.
6. Decompose any growth number into price and volume — inflation-led growth is borrowed
The repeatable method
- For any beat driven by one category, get the two components separately: average selling price and unit volume. Growth from price alone is a different asset than growth from units.
- Identify who caused the price change. Price rises the company chose (mix, premiumization) behave differently from price rises passed through from an input cost — the pass-through kind stops the moment the input normalizes and can reverse demand while it lasts.
- Trace the input cost upstream. Component inflation visible in a supplier's earnings will surface one or two links later in a retailer's comparable sales; the same shortage can read as a positive in one company's print and a fragility in another's.
- Check the comparison base — growth achieved while lapping a one-time event is worth more than the same number on an easy base.
- Then locate the structurally better dollars: marketplace fees, advertising, services — revenue that does not consume inventory — and ask whether they are growing fast enough to matter when the price effect ends.
Here: BBY beat and raised — comps 4.1% against a ~1% outlook, positive nearly everywhere, while lapping the Switch 2 launch — and the decomposition undercuts it: average PC selling prices rose mid-teens as memory costs increased, while unit volumes fell high single digits. The input is the same memory scarcity visible in this source's chip coverage, arriving two links downstream as a retailer's comp. The better dollars are growing: Marketplace at $300M quarterly GMV with FY27 raised to $1.3B, Best Buy Ads lifting gross margin, and AI glasses and collectibles more than doubling to add ~1 point of comp. FY27 comps guided to 1.9%–3% from −1% to +1%, with Q3 still positive "even as the company laps stronger Windows 10-driven computing demand."
Watch for
- PC unit volumes turning positive (the growth becomes real) or ASPs flattening while units stay negative (the comp collapses); memory prices normalizing; and Marketplace + Ads growth against the $1.3B target as the computing comparisons harden.
7. When a supply constraint caps a business, track the adoption rate of the workarounds — that separates a timing problem from a demand problem
The repeatable method
- Name the physical constraint precisely and identify the step in the sales motion it blocks (here: a customer must buy new servers before it can deploy the software).
- List every path the company offers that bypasses that step — running on hardware the customer already owns, a cloud-hosted version, a partner integration — and demand a disclosed growth rate for each.
- Test with the leading recurring metric, not revenue: if ARR accelerates during the constraint, demand was never the issue and the workarounds are converting.
- Separate the constraint's expected duration from its effect. "Lead times stabilizing" but "shortages and price increases persisting" with "customers delaying contract start dates" is a timing statement — pushed revenue, not lost revenue — provided bookings keep growing.
- Re-check next quarter whether the workaround mix is a permanent shift (which may change margins and competitive exposure) or a temporary detour that reverses when supply normalizes.
Here: NTNX printed record revenue +16% to $757M with ARR accelerating to 16% at $2.5B, a 37% FCF margin and 3,000+ customers added in FY26 — during the shortage. The workarounds are disclosed and growing: external storage and NC2 bookings both jumped sharply Q/Q, letting customers adopt "without replacing existing hardware or by moving workloads into the cloud," with NetApp support already winning large deals and management expecting acceleration in FY27. The honest caveat stays attached — shortages and price increases persist throughout FY27, with more customers delaying contract start dates — hence "a timing problem rather than a demand problem."
Watch for
- ARR decelerating while the workarounds keep growing (which would mean the detour is cannibalizing, not converting); contract start dates slipping further right; and whether NC2's cloud mix carries a structurally different margin than the on-prem motion.
8. Read the recurring-revenue metrics in the order they turn — and trust the backlog over the revenue line
The repeatable method
- Rank the disclosures by how early they move: net-new ARR and bookings first, then cRPO / current backlog, then total RPO, then reported revenue (which is largely last year's bookings arriving).
- Judge an inflection on the leading metrics and use revenue only to confirm. A company reporting 13–14% revenue growth on 8% backlog growth is reporting the past.
- Watch the second derivative on the leading metric: ARR growth accelerating (not merely high) is rare as a base scales, and is the strongest single signal in this family.
- Compare growth rates across the stack in the right direction — cRPO above revenue means the business signed more than it billed; the reverse means the reported number is being harvested from an older book.
- When a company guides growth down and margin up in the same breath, treat it as a declaration of which line it will defend, and model the margin promise as the reliable half.
Here: the whole spectrum in one issue. RBRK is the best case — subscription ARR +33%, accelerating from 32%, NRR above 119%, with the acquisition contributing zero. ESTC: cRPO accelerating to 21% and total RPO +27% against reported revenue of +15% — signing ahead of billing. OKTA: cRPO 12% → 14% with record non-Q4 bookings. ADSK: cRPO +12%, RPO $7.4B. And the warning case, WDAY: revenue +13% and subscription +14%, but total subscription backlog grew only 8% to $27.4B and FY28 subscription growth is guided to ~11% — offset by margin guidance raised +0.5pp to 31% now and at least 2 points of expansion promised for FY28.
Watch for
- Workday's backlog growth converging with (or staying below) revenue growth; Rubrik's ARR growth as the base crosses $2B; Elastic's cRPO holding above 20% now that the reacceleration is guided back-half weighted; and any company that changes which backlog metric it emphasizes.
9. Ask what is producing a record margin — cost removed or revenue added — then check the compounding engine underneath
The repeatable method
- When margin hits a record, attribute it: price increases, mix shift, operating leverage on growth, or costs structurally removed (automation, headcount, service deflection).
- Automation-driven margin is real but finite — a call deflected once cannot be deflected twice. Ask what percentage of the addressable cost has already been automated; the closer to the ceiling, the less runway remains.
- Then find the engine that compounds — the asset base, the float, the installed base — and read its growth rate. Efficiency gains are a stock; engine growth is a flow.
- If the engine is decelerating while margin expands, the earnings growth has a horizon. Model the point where automation savings are exhausted and earnings converge back toward the top line.
- A record margin printed alongside a falling share price usually means the market has already made this distinction — go looking for the decelerating engine rather than assuming an overreaction.
Here: HQY is the textbook case. Adjusted EBITDA margin hit a record 48% from 46%, sourced explicitly from automation — AI resolving 85% of routine chat inquiries and 55% of card-related phone contacts without an employee, with mobile MAUs +62% to 1.4M. But the compounding engine cooled: HSA assets grew 14%, down from 19%, to $37.9B, even as accounts hit a record 10.7M with record Q2 new-account sales and custodial revenue +10% to $176M. Shares "nevertheless fell sharply." Bottom Line: "the next test is whether these efficiency gains can keep earnings compounding faster than the high-single-digit top line."
Watch for
- The AI deflection rates approaching their ceiling (85% cannot become 170%); HSA asset growth stabilizing or falling further; Marketplace revenue finally becoming material; and margin expansion decelerating faster than revenue, which is when the story ends.
10. When regulation removes a structural advantage, re-underwrite the business model — not the growth rate
The repeatable method
- Identify whether a business's unit economics depended on a rule rather than on an operating capability — a duty exemption, a licensing gap, a classification loophole, a subsidy.
- If so, treat the rule's removal as permanent and re-derive the unit economics without it, rather than modelling a temporary growth dip.
- Read management's mitigation for what it costs structurally, not just in dollars. Building local warehousing to replace direct-from-origin shipping converts an asset-light model into an asset-heavy one — lower returns on capital even if revenue recovers.
- Check the domestic/core business separately; a company under regulatory pressure abroad and competitive pressure at home has no engine left to carry the transition.
- Distinguish capacity to fund the transition from evidence the transition works. A large cash pile answers solvency, never returns — the same test this source applies to AI capex.
Here: PDD — revenue +8%, decelerating from 11%, with Online Marketing Services +3% and Transaction Services 20% → 13%. The rule change is explicit: "the end of duty-free treatment for low-value parcels in the US and new European import fees are increasing fulfillment costs and reducing the appeal of shipping inexpensive products directly from China," with management warning of slower fulfillment and higher costs and responding by building local warehousing and fulfillment infrastructure. Domestically, Pinduoduo is fighting Alibaba, JD and social commerce for cautious consumers, and the first-party brand initiative is progressing more slowly than expected. Capacity is not the constraint — $67B of cash and short-term investments, operating cash flow +19% to $3.8B — but "investors are still waiting for evidence that all this spending can restart the growth engine."
Watch for
- Whether Temu discloses margin or fulfilment cost per order in the localized markets; Online Marketing Services growth (the domestic health check, and the higher-margin half); the first-party brand initiative getting a stated timeline; and any further jurisdictions adding low-value import fees.
11. When a beat-and-raise still falls, ask what the guidance added — not what it said
The repeatable method
- Reconstruct what the market already assumed before the print: the forward multiple, and specifically which announced opportunities were already inside the prior guidance.
- Compute the incremental information: a raise that merely confirms a previously-embedded opportunity adds enthusiasm without adding numbers.
- Read partnership announcements for whether they change the forecast or re-describe it. Look for the structural commitment (a warrant, a take-or-pay, a multi-year contract) as the part that is genuinely new.
- Put the multiple beside the growth durability rather than the growth rate — at a high multiple, the question is how many years of the current rate are already paid for.
- Then decide explicitly whether your disagreement with the market is about the business or about the price; they demand different evidence, and only the second is answered by valuation.
Here: MRVL beat, raised FY27 to ~$12B and FY28 to $18B, guided Q3 to $3.15B ahead of consensus (another ~15% sequential jump), grew Data Center +46% to 79% of sales, expanded the Google partnership backed by a six-year warrant agreement, and called CXL memory expansion a "home run" — and the shares fell. The stated reason is entirely about expectations: "over 50x forward earnings, and much of the Google opportunity through FY28 was already embedded in guidance." Same pattern this source has logged repeatedly — Cisco falling on a record quarter because only $7.5B of FY27 AI revenue was guided against the backlog, Applied Materials slipping after a record print, AMD and SpaceX falling on beats.
Watch for
- The H2 FY27 custom-silicon acceleration actually appearing on schedule, and FY28 custom revenue doubling as promised; whether the warrant translates into disclosed program wins; and the forward multiple compressing on a flat price, which is how an over-owned name digests its own good news.